T lymphocytes as therapeutic arsenal for patients with hematological malignancies
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference133 articles.
1. Donor lymphocyte infusion in myeloid disorders;Toprak;Transfus Apher Sci,2018
2. Donor lymphocyte infusion after allogeneic stem cell transplantation;Castagna;Transfus Apher Sci,2016
3. Donor lymphocyte infusions used to treat mixed-chimeric and high-risk patient populations in the relapsed and nonrelapsed settings after allogeneic transplantation for hematologic malignancies are associated with high five-year survival if persistent full donor chimerism is obtained or maintained;Caldemeyer;Biol Blood Marrow Transplant,2017
4. Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival;Thompson;Br J Haematol,2017
5. Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus-host disease-guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractory/relapsed acute leukemia;Yan;Biol Blood Marrow Transplant,2017
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Allogeneic hematopoietic stem cell transplant recipients in Spain: Human leukocyte antigen characteristics and diversity by high‐resolution analysis;HLA;2021-01-17
2. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases;Drug Design, Development and Therapy;2020-11
Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases
3. Application of Chimeric Antigen Receptor T Cells in the Treatment of Hematological Malignancies;BioMed Research International;2020-10-01
4. Pretreatment neutrophil-to-lymphocyte ratio is a predictive biomarker for EGFR TKI-treated patients with advanced EGFR- mutant Non-small cell lung cancer;Translational Cancer Research;2020-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3